Stenting In Heart Attack Patients Cleared By FDA; Guidant’s Multi-Link Is First
This article was originally published in The Gray Sheet
Executive Summary
Guidant is now the only company with a coronary stent indicated for use in heart attack patients in the U.S. The firm announced Aug. 14 that the Multi-Link stent platform received FDA approval via PMA supplement
You may also be interested in...
Small-Vessel Pixel Stent Receives Alloy Upgrade In Next Generation – Guidant
Guidant expects FDA approval of its next-generation Pixel stent for small vessels within the coming weeks
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.